UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 2006
MYRIAD GENETICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 0-26642 | 87-0494517 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
320 Wakara Way
Salt Lake City, Utah 84108
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (801) 584-3600
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Page 1 of 4 pages
| ITEM 1.01 | Entry into a Material Definitive Agreement |
On June 16, 2006, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Myriad Genetics, Inc. (“Myriad”) approved the 2006 fiscal year cash bonuses and 2007 fiscal year annual base salaries effective July 1, 2006, of Myriad’s Chief Executive Officer and other executive officers. The Compensation Committee also established Myriad’s cash bonus incentive plan for executive officers for fiscal year 2007 which provides for the discretionary award of cash bonuses based on overall corporate performance together with a subjective assessment of each officers’ goals related to the officer’s areas of responsibility.
The 2006 fiscal year cash bonuses for Myriad’s Chief Executive Officer and other executive officers were determined by the Compensation Committee based upon overall corporate performance together with a subjective assessment by the Compensation Committee of the achievement of goals relating to the individual areas of responsibility for each officer.
The fiscal year 2006 base salaries and cash bonuses and the fiscal year 2007 base salaries for Myriad’s named executive officers are listed in Exhibit 10.1 filed herewith and incorporated herein by reference. Additional information regarding compensation of Myriad’s named executive officers will be included in Myriad’s proxy statement to be filed in connection with its 2006 Annual Meeting of Shareholders.
| ITEM 9.01 | Financial Statements and Exhibits. |
| (d) | The following exhibit is filed with this report: |
| Exhibit Number |
Description | |
| 10.1 | Fiscal year 2006 base salaries and cash bonuses and fiscal year 2007 base salaries for Myriad’s named executive officers. | |
Page 2 of 4 pages
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MYRIAD GENETICS, INC. | ||||||||
| Date: June 20, 2006 | By: | /s/ Peter D. Meldrum | ||||||
| Peter D. Meldrum | ||||||||
| President and Chief Executive Officer | ||||||||
Page 3 of 4 pages
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 10.1 | Fiscal year 2006 base salaries and bonuses and fiscal year 2007 base salaries for Myriad’s named executive officers. | |
Page 4 of 4 pages